Details for New Drug Application (NDA): 207831
✉ Email this page to a colleague
The generic ingredient in CLOFARABINE is clofarabine. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clofarabine profile page.
Summary for 207831
Tradename: | CLOFARABINE |
Applicant: | Gland Pharma Ltd |
Ingredient: | clofarabine |
Patents: | 0 |
Pharmacology for NDA: 207831
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Suppliers and Packaging for NDA: 207831
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOFARABINE | clofarabine | SOLUTION;INTRAVENOUS | 207831 | ANDA | Gland Pharma Limited | 68083-386 | 68083-386-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-386-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
CLOFARABINE | clofarabine | SOLUTION;INTRAVENOUS | 207831 | ANDA | Fosun Pharma USA Inc. | 72266-108 | 72266-108-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72266-108-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20MG/20ML (1MG/ML) | ||||
Approval Date: | Oct 31, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription